[Federal Register Volume 79, Number 17 (Monday, January 27, 2014)] [Notices] [Page 4342] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2014-01436] ----------------------------------------------------------------------- DEPARTMENT OF DEFENSE Department of the Army Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Benzonapthyridine Composition and Uses AGENCY: Department of the Army, DoD. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 13/640,832, entitled ``Benzonapthyridine Composition and Uses,'' filed on April 13, 2011. The United States Government, as represented by the Secretary of the Army, has rights to this invention. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012. FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619- 6664, both at telefax (301) 619-5034. SUPPLEMENTARY INFORMATION: The invention relates to compositions comprising benzonapthridine small molecule immune potentiators (SMIPs) that are capable of stimulating or Modulating an immune response in a subject that has had pre- or post- exposure to a pathogen such as hemorrhagic fever virus. Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2014-01436 Filed 1-24-14; 8:45 am] BILLING CODE 3710-08-P